Ken Saijo
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Geriatrics and Gerontology top 10%
- Frailty in Older Adults
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 6
-
- Lung Cancer Treatments and Mutations 8
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Chikashi Ishioka (40 shared papers)Hidekazu Shirota (25 shared papers)Hiroo Imai (31 shared papers)Hideki Shimodaira (10 shared papers)Tadashi Katoh (7 shared papers)Keigo Komine (27 shared papers)Masanobu Takahashi (27 shared papers)Masahiro Takahashi (16 shared papers)
In The Last Decade
Ken Saijo
43 papers receiving 521 citations
Peers
Comparison fields: 5 of 75
- Otorhinolaryngology 68
- Geriatrics and Gerontology 48
- Oncology 232
- Pulmonary and Respiratory Medicine 133
- Cancer Research 52
Countries citing papers authored by Ken Saijo
This map shows the geographic impact of Ken Saijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Saijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Saijo more than expected).
Fields of papers citing papers by Ken Saijo
This network shows the impact of papers produced by Ken Saijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Saijo. The network helps show where Ken Saijo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Saijo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 78 | |
| 2 | 2018 | 65 | |
| 3 | 2017 | 60 | |
| 4 | 2012 | 41 | |
| 5 | 2014 | 34 | |
| 6 | 2019 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2016 | 17 | |
| 9 | 2019 | 16 | |
| 10 | 2017 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2017 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2016 | 10 | |
| 17 | 2016 | 10 | |
| 18 | 2019 | 10 | |
| 19 | Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study | 2022 | 7 |
| 20 | 2016 | 7 |
About Ken Saijo
Ken Saijo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Otorhinolaryngology, having authored 47 papers that have together received 530 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Head and Neck Cancer Studies (6 papers), Protein Degradation and Inhibitors (5 papers) and Colorectal and Anal Carcinomas (4 papers). The work is most often cited by research in Otorhinolaryngology (68 citations), Geriatrics and Gerontology (48 citations), Oncology (232 citations), Pulmonary and Respiratory Medicine (133 citations) and Cancer Research (52 citations). Ken Saijo has collaborated with scholars based in Japan, Canada and Greece. Frequent co-authors include Chikashi Ishioka, Hidekazu Shirota, Hiroo Imai, Hideki Shimodaira, Tadashi Katoh, Keigo Komine, Masanobu Takahashi, Masahiro Takahashi, Shin Takahashi and Akifumi Oda. Their work appears in journals such as Cancer Science, International Journal of Clinical Oncology, Oncology, Chemotherapy and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.